- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment.
October 1, 2019
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma.
September 30, 2019
Imaging of Small Renal Masses before and after Thermal Ablation.
September 30, 2019
Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
September 30, 2019
Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis.
September 27, 2019
Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of Survival.
September 27, 2019
Very late locally recurrent chromophobe renal cell carcinoma: 15 years following radical nephrectomy for low-stage disease.
September 26, 2019
Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
September 25, 2019
Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma.
September 25, 2019
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study.
September 24, 2019
Ubiquitin-specific peptidase 46 (USP46) suppresses renal cell carcinoma tumorigenesis through AKT pathway inactivation.
September 24, 2019
Human renal adipose tissue from normal and tumor kidney: its influence on renal cell carcinoma.
September 24, 2019
The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results.
September 23, 2019